血清NGAL和淀粉样蛋白A在糖尿病肾病诊断中的价值被引量：3

Diagnostic value of serum NGAL and amyloid A levels in diabetic nephropathy

导出

摘要目的探讨血清中性粒细胞明胶酶相关脂质运载蛋白(NGAL)和血清淀粉样蛋白A(SAA)在糖尿病肾病(DN)诊断中的价值。方法用ELISA检测58例单纯糖尿病、53例早期DN、43例临床DN及50例健康对照者血清NGAL和SAA水平。结果单纯糖尿病、早期和临床DN组血清NGAL、SAA水平均高于对照者(P<0.01),其中以临床DN组最高(P<0.01)。NGAL对DN诊断的敏感性、特异性分别为63.2%、89.5%,而SAA分别为83.1%、51.4%。结论血清NGAL和SAA可作为DN的监测指标。 Objective To investigate the diagnostic value of serum neutrophil gelatinase-associated lipocalin（NGAL） and amyloid A（SAA） levels in diabetic nephropathy（DN）. Serum levels of NGAL and SAA were detected by MethodsELISA in 58 patients with simple diabetes, 53 with early DN, 43 with clinical DN, and 50 healthy controls. Results Serum levels of NGAL and SAA were higher in simple diabetes and early and clinical DN groups than in control group（P〈0.01）,with the highest in clinical DN group（P〈0.01）. The sensitivity and specificity of NGAL for the diagnosis DN were respectively 63.2% and 89.5%, while those of SAA were 83.1% and 51.4%. Conclusion Serum levels of NGAL and SAA can serve as monitoring indexes for DN.

作者钟毓琼曾小变叶志东 ZHONG Yu-qiong;ZENG Xiao-bian;YE Zhi-dong(Second Affiliated Hospital,Guangdong Medical University,Zhanjiang 524000,China)

机构地区广东医科大学附属第二医院

出处《广东医科大学学报》 2018年第4期411-413,共3页 Journal of Guangdong Medical University

关键词中性粒细胞明胶酶相关脂质运载蛋白淀粉样蛋白A 糖尿病肾病 neutrophil gelatinase-associated lipocalin amyloid A diabetic nephropathy

分类号 R587 [医药卫生—内分泌]

引文网络
相关文献

参考文献3

1王春霞,甄宏斌,朱文鹏,乔慧章,杜凯,王利涛.2型糖尿病患者早期肾病生化指标变化观察[J].人民军医,2011,54(11):990-992. 被引量：17
2白伟,刘建凤,王艳霞,郭铁标.2型糖尿病肾病患者血清淀粉样蛋白A水平[J].中国中西医结合肾病杂志,2011,12(4):337-338. 被引量：6
3官莉莉,顾维正,朱麒钱,斯徐伟,马静波,叶飞,丁建仁,谢科杰.尿κ轻链早期诊断糖尿病肾病的价值初探[J].医师进修杂志,2004,27(2):20-22. 被引量：5

二级参考文献18

1Wild S, Roglic G, Green A, et al. Global prevalence of diabetes:Estimates for the year 2000 and projections for 2030[J]. Diabetes Care, 2004,27(5) : 1047-1053.
2Yng W, Lu J, Weng J, etal. Prevalence of diabetes among men and women in China[J]. New Engl J Med, 2010,362(12): 1090-1101.
3Kramer HJ, Nguyen QD, Curhan G, et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus[J]. JAMA,2003,289(24) : 327a-a277.
4Rigalleau V, Beauvieux MC, Le Moigne F,et al. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomemlar filtration rate in diabetes[J]. Diabetes Metab, 2008,34(5) :482-489.
5Jeon YK, Kim MR, Huh JE,et al. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes[J]. J Korean Med Sei, 2011,26(2), 258-263.
6Oddoze C, Morange S, Portugal H,et al. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes[J]. Am J Kidney Dis, 2001,38(2) :310-316.
7Kalarmooriya A, Holbrook I, Jennings P, et al. Serum cystatin C, ev.zymuria, tubular proteinuria and early renal insult in type 2 diabetes[J]. Br J Biomed Sci,2007,64(3) : 121-123.
8SHIMIZU H,NEGISHI M,SHIMOMURA Y,et al. Change in urinary retinol binding protein excretion and other indices of renal tubular damage in patients with no-insulin dependent diabetes[J].Res Clin Pract,1992,18:207-213.
9SACKETT D L.A primer on the precision and accuracy of the clinical examination[J].JAMA,1992,267(19):2 638-2 645.
10ROBINSON E L,GOWLAND E,WARD I D,et al. Radioimmunoassay of free light chains of immunoglobulins in urine[J].Clin Chem,1982,28:2 254-2 258.